StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
This month
5
This week
1
This year
5
Today
1
Yesterday
1
Publishing Date
2024 - 04 - 24
1
2024 - 04 - 19
1
2024 - 04 - 16
1
2024 - 04 - 11
1
2024 - 04 - 04
1
Sector
Health technology
5
N/a
2
Tags
Active
10
Agreement
8
Ajovy
8
Alzheimer's
9
America
38
Application
11
Approval
13
Asia
13
Austedo
9
Avt02
11
Avt04
11
Biosimilar
42
Business
12
Cancer
21
Children
18
Clinical-trials-phase-iii
8
Collaboration
9
Conference
20
Dermatitis
8
Disease
36
Drug
44
Dupixent
34
Earnings
14
Europe
15
Events
10
Expected
12
Fda
22
Financial
21
Global
111
Growing
17
Growth
133
Health
11
Libtayo
8
License
11
Liver
8
Market
314
Migraine
9
N/a
516
Pharm-country
18
Pharma
12
Pharmaceuticals
9
Phase 3
15
Positive
14
Reach
16
Report
95
Research
59
Respiratory
10
Results
48
Review
8
Set
13
Stelara
12
Study
21
System
11
Teva
53
Therapeutics
64
Therapy
14
Treatment
76
Trial
12
Update
20
Year
8
Entities
Alvotech lux holdings s.a.s.
2
Johnson & johnson
1
Kamada ltd.
2
Teva pharmaceutical industries limited
3
Teva pharmaceutical industries ltd
5
Symbols
ABB
3
ABBNY
3
ABLZF
3
ABT
5
ACRV
3
AMSIY
3
AMSYF
3
APA
3
APPN
4
ARCXF
3
AREB
3
ARVL
21
AVGO
4
AVXL
3
BMO
5
BTAI
3
CC
3
CCL
4
CM
5
CUK
4
DD
3
ENPH
3
FNCTF
18
FRBA
3
GOOG
3
GOOGL
3
HON
7
HOWL
3
IT
7
JNJ
18
KULR
3
LH
4
MDNA
3
MDNAF
3
MEDE
6
MILOF
3
MOB
3
MS
6
MT
3
NIPNF
3
NVS
5
NVSEF
4
PFE
4
PPRUF
3
PPRUY
3
PRGO
5
RCAT
3
RY
3
SAP
3
SAPGF
3
SGBX
3
SMFL
7
SNY
13
SNYNF
13
SPGI
3
TAK
4
TEVA
3
TEVJF
5
TGTX
3
VZ
4
Exchanges
Nasdaq
5
Nyse
4
Crawled Date
2024 - 04 - 24
1
2024 - 04 - 19
1
2024 - 04 - 16
1
2024 - 04 - 11
1
2024 - 04 - 05
1
Crawled Time
00:00
1
08:00
1
10:00
1
13:00
1
23:00
1
Source
www.biospace.com
3
www.globenewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
For
symbols :
TEVJF
save search
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published:
2024-04-24
(Crawled : 08:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
1.04%
|
O:
1.12%
H:
1.48%
C:
-0.07%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-1.02%
|
O:
-1.02%
H:
0.0%
C:
0.0%
avt05
simponi
biosimilar
for
topline
results
study
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published:
2024-04-19
(Crawled : 10:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
4.96%
|
O:
1.16%
H:
7.28%
C:
1.3%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
1.76%
|
O:
1.76%
H:
0.0%
C:
0.0%
humira
biosimilar
approved
for
agreement
Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Published:
2024-04-16
(Crawled : 13:00)
- biospace.com/
TEVA
|
$13.01
-0.68%
7.5M
|
Health Technology
|
-1.66%
|
O:
0.23%
H:
0.23%
C:
-1.28%
austedo
for
meeting
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published:
2024-04-11
(Crawled : 23:00)
- biospace.com/
TEVA
|
$13.01
-0.68%
7.5M
|
Health Technology
|
-6.06%
|
O:
-1.01%
H:
2.04%
C:
1.17%
ajovy
for
teva
trial
migraine
china
results
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published:
2024-04-04
(Crawled : 00:00)
- biospace.com/
TEVA
|
$13.01
-0.68%
7.5M
|
Health Technology
|
-7.86%
|
O:
-0.42%
H:
0.0%
C:
0.0%
candidate
biosimilar
global
for
teva
agreement
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.